Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lawrence Edwards

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
The American Journal of Medicine|October 25, 2006
Case 7: differential diagnosis of advanced goutN Lawrence Edwards
Cleveland Clinic Journal of Medicine|September 30, 2008
The role of hyperuricemia and gout in kidney and cardiovascular diseaseN Lawrence Edwards
Current Rheumatology Reports|December 17, 2010
Quality of care in patients with gout: why is management suboptimal and what can be done about it?N Lawrence Edwards
Rheumatology (Oxford, England)|May 19, 2009
Febuxostat: a new treatment for hyperuricaemia in goutN Lawrence Edwards
The American Journal of Medicine|October 25, 2006
Case 9: initiation of urate-lowering therapy for advanced gout complicated by chronic renal insufficiencyN Lawrence Edwards
Drugs|August 30, 2008
Febuxostat : a viewpoint by N. Lawrence EdwardsN Lawrence Edwards
Current Opinion in Rheumatology|April 3, 2009
The role of hyperuricemia in vascular disordersN Lawrence Edwards
Arthritis and Rheumatism|September 2, 2008
Treatment-failure gout: a moving targetN Lawrence Edwards
The American Journal of Medicine|October 25, 2006
Case 6: maintenance therapy for simple intermittent goutN Lawrence Edwards
Postgraduate Medicine|August 26, 2016
Overview of Serum Uric Acid Treatment Targets in Gout: Why Less Than 6 mg/dL?Gary Ruoff, N Lawrence Edwards
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
The American Journal of Medicine|October 25, 2006
Case 7: differential diagnosis of advanced goutN Lawrence Edwards
Cleveland Clinic Journal of Medicine|September 30, 2008
The role of hyperuricemia and gout in kidney and cardiovascular diseaseN Lawrence Edwards
Current Rheumatology Reports|December 17, 2010
Quality of care in patients with gout: why is management suboptimal and what can be done about it?N Lawrence Edwards
Rheumatology (Oxford, England)|May 19, 2009
Febuxostat: a new treatment for hyperuricaemia in goutN Lawrence Edwards
The American Journal of Medicine|October 25, 2006
Case 9: initiation of urate-lowering therapy for advanced gout complicated by chronic renal insufficiencyN Lawrence Edwards
Drugs|August 30, 2008
Febuxostat : a viewpoint by N. Lawrence EdwardsN Lawrence Edwards
Current Opinion in Rheumatology|April 3, 2009
The role of hyperuricemia in vascular disordersN Lawrence Edwards
Arthritis and Rheumatism|September 2, 2008
Treatment-failure gout: a moving targetN Lawrence Edwards
The American Journal of Medicine|October 25, 2006
Case 6: maintenance therapy for simple intermittent goutN Lawrence Edwards
Postgraduate Medicine|August 26, 2016
Overview of Serum Uric Acid Treatment Targets in Gout: Why Less Than 6 mg/dL?Gary Ruoff, N Lawrence Edwards
Pageof 7